U.S. Stem Cell, Inc. 4
4 · U.S. Stem Cell, Inc. · Filed Feb 17, 2017
Insider Transaction Report
Form 4
U.S. Stem Cell, Inc.BHRT.OB
Comella Kristin C
Chief Science Officer
Transactions
- Award
Stock Options (right to buy)
2017-02-06+5,000,000→ 11,697,748 totalExercise: $0.00Exp: 2027-02-06→ Common Stock (5,000,000 underlying)
Footnotes (1)
- [F1]1,250,000 vest on 02/06/2018, 1,250,000 vest on 02/06/2019, 1,250,000 vest on 02/06/2020, 1,250,000 vest on 02/06/2021.